Signaling by LTK in cancer
REACTOME PATHWAYThe Signaling by LTK in cancer pathway (Reactome ID: R-HSA-9842640) involves 5 genes and is affected by 30 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Signaling by LTK in cancer
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | pictilisib | — | 25 |
| 2 | ly294002 | — | 11 |
| 3 | Sirolimus | — | 300 |
| 4 | plumbagin [Supplementary Concept] | — | 300 |
| 5 | pd98059 | — | 7 |
| 6 | alsterpaullone | — | 12 |
| 7 | kenpaullone | — | 8 |
| 8 | isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from | — | 300 |
| 9 | Sorafenib | — | 300 |
| 10 | trametinib | — | 296 |
| 11 | withaferin | — | 300 |
| 12 | Wortmannin | — | 300 |
| 13 | alpelisib | — | 227 |
| 14 | tyrphostin ag 1478 | — | 4 |
| 15 | Clotrimazole | — | 296 |
| 16 | sp600125 | — | 117 |
| 17 | fisetin | — | 78 |
| 18 | Progesterone | — | 299 |
| 19 | 2-Chloroadenosine 2-Chloroadenosine. | — | 300 |
| 20 | Benzalkonium Compounds | — | 299 |
| 21 | Calcimycin | — | 216 |
| 22 | daph | — | 2 |
| 23 | Diphenhydramine | — | 14 |
| 24 | ha1004 | — | 4 |
| 25 | Lithocholic Acid | — | 300 |
| 26 | Loratadine | — | 296 |
| 27 | trequinsin hydrochloride | — | 1 |
| 28 | torin 1 | — | 10 |
| 29 | Quercetin | — | 300 |
| 30 | Resveratrol | — | 298 |
About the Signaling by LTK in cancer Pathway
The Signaling by LTK in cancer pathway is catalogued in Reactome (ID: R-HSA-9842640) and involves 5 genes. In the BiohacksAI corpus, 30 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include MAPK1, MAPK3, PIK3CB, PIK3R1, PIK3R2.